Oct 062015
Daniel Fells, New York Giants (December 21, 2014)

Daniel Fells – © USA TODAY Sports Images

[contentblock id=1 img=html.png]

It has been revealed that the staph infection that has sidelined New York Giants tight end Daniel Fells for the season is MRSA (methicillin-resistant Staphylococcus aureus), a potentially very serious infection that is resistant to common antibiotics and is very contagious as it is spread by contact. In recent years, MRSA outbreaks hit both the Cleveland Browns and Tampa Bay Buccaneers, ending the careers of some players.

Because of the situation, the Giants have had their team facilities professionally scrubbed to contain any possible spread to other players and team officials.

“We are working with infectious disease specialists, and we have defined protocols that we are following in consultation with the Duke Infection Control Outreach Network and local infectious disease specialists,” said Giants Senior Vice President of Communications Pat Hanlon. “Those protocols are being followed carefully.”

Fells reportedly underwent multiple surgeries this past weekend in order to treat this potentially life- and career-threatening infection. Amputation is sometimes required to stem the infection.

The audio of Tuesday’s WFAN Radio interview with CB Prince Amukamara is available on CBS New York’s website.

The New York Giants defense is currently 1st against the run (69.8 yards per game) and 32nd against the pass (316.3 yards per game).

Opposing teams have averaged just 3.1 yards per carry.

The Giants are 24th in rushing (93.0 yards per game).

The Giants are tied for second in the NFL with a plus-six turnover differential, with only two giveaways and eight takeaways.

The Giants are 34-10 (.773) in the month of October under Head Coach Tom Coughlin.

Print Friendly, PDF & Email

Eric Kennedy

Eric Kennedy is Editor-in-Chief of BigBlueInteractive.com, a publication of Big Blue Interactive, LLC. Follow @BigBlueInteract on Twitter.

Sorry, the comment form is closed at this time.